The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
HVEGF-IN-1; N-(2-(4-((4-(2-(diethylamino)ethoxy)phenyl)amino)quinazolin-2-yl)phenyl)-3-(4-methylpiperazin-1-yl)propanamide; CAS No.: 1637443-98-1; HVEGF-IN-1. PROPERTIES: HVEGF-IN-1 is a small molecule compound appearing as a white to off-white solid. This compound has a molecular weight in the range of 300-400 g/mol. It exhibits limited water solubility but is soluble in DMSO and dimethylformamide. HVEGF-IN-1 should be stored at -20 C in a tightly sealed container. It is sensitive to moisture and light. Safety considerations include potential eye and skin irritation, so protective equipment is recommended. APPLICATIONS: HVEGF-IN-1 is investigated in angiogenesis research for its potential effects on vascular endothelial growth factor (VEGF) signaling. It is used in preclinical models to study blood vessel formation and remodeling. In pharmacology, HVEGF-IN-1 serves as a tool to explore therapeutic approaches for angiogenesis-related diseases. These applications are described in vascular biology literature and pharmaceutical science research papers.